Breast cancer panel halves turnaround time: Wei Shen, Ph.D.

Wei Shen, Ph.D., explains how Mayo Clinic Laboratories' new breast cancer panel provides rapid results to guide critical treatment decisions.(00:32)
 Could you provide our listeners with a little bit about yourself and your background? (01:28)
 Could you give us a brief overview of the new rapid hereditary breast cancer panel? (03:42)
 Can you describe a little bit of the rationale behind the design and how it differs from similar tests? (05:03)
 Can you tell us a little bit more about which patients should have this testing? (06:00)
 How are the results of the hereditary breast cancer panel used in patient care? (08:14)
 Is there anything else you would like to add about the panel?